⏱ News is delayed by 15 minutes. Sign in for real-time access.
Sign in
JNJ News
Johnson & Johnson
Es posible que tenga derecho a recibir un pago en efectivo de un Acuerdo de Demanda Colectiva si se realizó una evaluación de la piel de Skin360® utilizando cualquier versión de Skin360®, incluidas Neutrogena® Skin360®, NeoStrata® Skin360® y cualquier
prnewswire.com
JNJ
KVUE
You May Be Entitled to a Cash Payment From a Class Action Settlement if You Performed a Skin360® Skin Assessment Using Any Version of Skin360®, Including Neutrogena® Skin360®, NeoStrata® Skin360®, and Any Skin360®Collaborations With Other Entities, While
prnewswire.com
JNJ
KVUE
Japanese Gastroenterologists Support Earlier Advanced Therapy in Ulcerative Colitis, but Practice Lags Behind Belief, Spherix Global Insights Finds
globenewswire.com
ABBV
JNJ
MRK
SNY
Clark Atlanta University—First Stop on “At the Vanguard: Making and Saving History at HBCUs” Nine-city Tour
globenewswire.com
CBRE
GOOGL
JNJ
SO
TJX
TM
Canada ICT Market (2026-2031) - Growth Driven by Accelerating Digital Transformation
globenewswire.com
MSFT
AMZN
CSCO
GOOG
IBM
ORCL
CRM
SHOP
LSPD
NOW
PANW
ZS
FTNT
CDNS
SNPS
AMD
NVDA
INTC
MU
AMAT
LRCX
KLAC
TEL
NXPI
ON
ADI
TXN
AEHR
TER
PLTR
AI
SMCI
DELL
HPQ
STX
WDC
REGN
GILD
BIIB
CRSP
XOM
CVX
NEE
DUK
SO
PCG
ETSY
PYPL
QCOM
MRVL
ADSK
CDW
ACN
CSGS
NTAP
VRTX
MRNA
BMY
AMGN
AZN
PFE
JNJ
GOOGL
AAPL
META
NFLX
TSLA
GE
BA
RTX
LMT
GD
HON
CAT
DE
ROKU
WIX
RCL
CCL
NCLH
ATOS
New Technologies and Achievements Make Concentrated Debuts, Highlighting CIFTIS as a Platform for Innovation
globenewswire.com
MIND
JNJ
CAR T-cell Therapy for NHL Clinical Trial Landscape Expands: Over 70 Companies Advancing Next-Generation Therapies | DelveInsight
globenewswire.com
NVS
ALLO
LEGN
CBIO
MBIO
CRSP
INCY
IMPP
SANA
VOR
CARG
AUTL
ARCL
LYEL
PRE
BEAM
CART
TAK
AZN
MRK
BMY
GEN
DGX
GMAB
ABBV
RLGT
CRGO
JNJ
GILD
JAZZ
SYBX
CASI
ATRA
SHEN
BIIB
VREX
The Galien Foundation Announces Nominees for the Inaugural 2026 Prix Galien Patient First Award in Honor of Michael J. Fox
prnewswire.com
AGIO
AZN
AMGN
ARDX
BDX
BMY
CGON
FERG
GILD
JNJ
UTHR
MRK
NVS
PFE
PRM
IQV
URGN
Immuno-Oncology Pioneer Dr. Michael Kalos Joins Kos Biotechnology Partners as Venture Partner
prnewswire.com
LLY
JNJ
NVS
Johnson & Johnson Receives CE Marking for ACUVUE OASYS MAX Reusable Contact Lenses
businesswire.com
JNJ